Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
241 participants
OBSERVATIONAL
2016-09-01
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of a Mobile App on Pregnant Women's Prenatal Genetic Testing Decision-making
NCT05055700
Returning Genetic Results on Arsenic Susceptibility
NCT05072132
Family Genetics Health Education and Healthy Behaviors
NCT01498276
Examining Choice Architecture for Genetic Testing Decisions
NCT04372888
Usefulness of Home Pregnancy Testing
NCT00390754
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Routine check up including genetic testing
Intervention is a routine check up including preemptive genetic testing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* informed consent for genetic testing
* informed consent for study participation
Exclusion Criteria
* renal replacement dependency
* pregnancy
* active cancer disease
* no informed consent for genetic testing or study participation
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Robert Bosch Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. med. Mark Dominik Alscher
Medical Director, Managing Director
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RBK 358
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.